Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
<h4>Background</h4>A few studies focused on statin therapy as specific prophylactic measures of contrast-induced nephropathy have been published with conflicting results. In this meta-analysis of randomized controlled trials, we aimed to assess the effectiveness of short-term high-dose s...
Guardado en:
Autores principales: | Yongchuan Li, Yawei Liu, Lili Fu, Changlin Mei, Bing Dai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/753f1bed6cc24b159eda644f483f7f79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Jing-Zhan Zhang, et al.
Publicado: (2017) -
Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
por: Thongtang N, et al.
Publicado: (2020) -
The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures – Systematic review and meta-analysis of randomized controlled trials
por: Raymond Pranata, et al.
Publicado: (2021) -
Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Yebei Li, et al.
Publicado: (2021) -
Left Ventricular End-Diastolic Pressure and B-Type Natriuretic Peptide Levels Guidance of Low-Dose Furosemide Treatment to Prevent Contrast-Induced Nephropathy in Patients with Percutaneous Coronary Intervention: A Randomized Controlled Trial
por: Guoqiang Gu, et al.
Publicado: (2021)